Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.
Fed’s Waller, leaning against March cut, sees easings later in year
Federal Reserve Governor Christopher Waller opposes a rate cut at the upcoming policy meeting. He suggests future cuts are possible if inflation pressures decrease. Waller